Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsBUCCALGeneric

STRIANT

TESTOSTERONE

Standard Dose
30MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview STRIANT is listed in Drugs@FDA under application 021543 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TESTOSTERONE Form and strength TABLET, EXTENDED RELEASE;BUCCAL - 30MG Sponsor AUXILIUM PHARMS LLC Submission history Latest submission status date: 2016-10-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview STRIANT is listed in Drugs@FDA under application 021543 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TESTOSTERONE Form and strength TABLET, EXTENDED RELEASE;BUCCAL - 30MG Sponsor AUXILIUM PHARMS LLC Submission history Latest submission status date: 2016-10-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.